Learn More
Apexbio Technology LLC Cefpodoxime Proxetil 87239-81-4 10mM (in 1mL DMSO)

Supplier: Apexbio Technology LLC B49735.1
Cefpodoxime Proxetil is an oral prodrug belonging to the third-generation cephalosporin antibiotics After absorption it undergoes enzymatic hydrolysis in vivo converting to the active metabolite cefpodoxime Cefpodoxime exerts antibacterial activity by binding bacterial penicillin-binding proteins (PBPs) and inhibiting peptidoglycan synthesis thus preventing proper cell wall formation and ultimately leading to bacterial growth inhibition Cefpodoxime Proxetil is routinely employed in biomedical research studies to evaluate its antibacterial spectrum pharmacokinetics bioavailability and bacterial resistance mechanisms Additionally researchers utilize this compound for investigating antibacterial potential via in vitro and in vivo experiments with typical IC50 values varying based on bacterial strains and experimental conditions
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.